自抑制揭示ATR蛋白激酶是骨髓瘤中西斯普拉丁敏感性的关键调解者
Janice S Pereira1, Gabriel Rosa1, Aine Pears1
1Department of Natural Sciences, Faculty of Science & Technology, Middlesex University, London, UK.
Cancer medicine
|March 6, 2026
概括
自增强了骨髓瘤 (OS) 中的化学抵抗. 抑制ATR (阿塔克西亚长和Rad3相关蛋白质) 阻断DNA损伤信号传递和自,改善OS细胞中的西斯的敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 骨髓瘤 (OS) 是最常见的原发性骨癌.
- 在OS中抗化疗导致患者的治疗结果不佳.
- 自在OS化学抵抗中的作用需要进一步研究.
研究的目的:
- 为了研究自在骨髓瘤化学抵抗中的作用.
- 为了识别连接DNA损伤信号,自和化学抵抗的上游调节者.
- 评估ATR作为一种潜在的治疗点,用于提高OS患者的化疗敏感性.
主要方法:
- 对不同级别和阶段的OS瘤中自水平的分析.
- 在具有和没有自抑制 (ATG7淘汰赛) 的HOS-143B细胞中对西斯 (CIS) 敏感性的评估.
- 激酶查以确定受自抑制影响的信号通路.
- 研究ATR在p53酸化,DNA损伤反应 (DDR) 和自中的作用.
主要成果:
- 较高的自水平与先进的OS和较差的结果相关.
- 通过ATG7淘汰抑制自会显著提高OS细胞中的CIS敏感性.
- 抑制ATR通过促进细胞灭绝,减少p53酸化和阻断CIS处理的OS细胞的自性来增加CIS的敏感性.
结论:
- 抑制ATR是一种新的骨髓瘤治疗策略.
- 准ATR同时破坏DNA损伤信号和自,增强CIS的敏感性.
- 抑制ATR可以降低化疗剂量,限制毒性,并改善OS患者的生存率.
相关概念视频
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway
6.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.0K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
The Intrinsic Apoptotic Pathway
9.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
DNA Damage can Stall the Cell Cycle
10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle
3.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K


